Clinical Trials Browser

Phase 1/2 × Lymphoma, T-Cell, Peripheral × Cisplatin × Clear all

NCT05441761 2022-07-01

Mitoxantrone Hydrochloride Liposomes in Combination With GDP in Relapsed/Refractory PTCL

Phase 1/2 Unknown

Lymphoma, T-Cell, Peripheral